• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉阻塞、糖尿病性和葡萄膜炎性黄斑水肿的视力:中心凹下视网膜厚度和椭圆体带分析。

Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.

机构信息

Clearside Biomedical, Alpharetta, Georgia.

Clearside Biomedical, Alpharetta, Georgia.

出版信息

Ophthalmol Retina. 2021 Jul;5(7):633-647. doi: 10.1016/j.oret.2020.10.016. Epub 2020 Oct 29.

DOI:10.1016/j.oret.2020.10.016
PMID:33130256
Abstract

PURPOSE

This study assessed relationships between best-corrected visual acuity (BCVA), central subfield thickness (CST), and ellipsoid zone (EZ) integrity in macular edema (ME) patients.

DESIGN

Post hoc analysis of 6 clinical trials, which included verified diagnoses, protocol refractions, and reading center assessment of OCT images.

PARTICIPANTS

Participants (n = 1063) were diagnosed with ME from retinal vein occlusion (RVO), diabetic retinopathy (DR; diabetic macular edema, DME), or noninfectious uveitis (NIU).

METHODS

For CST, 2 clinical trials for each disorder were analyzed. For EZ, 3 studies across 2 disorders were analyzed.

MAIN OUTCOME MEASURES

Primary outcomes were correlations between BCVA and CST, and between BCVA and 4 central subfield EZ grades.

RESULTS

For baseline BCVA and CST, Pearson correlation coefficients were: ME from RVO, -0.56 (774 eyes; 95% confidence interval [CI], -0.61 to -0.51; P < 0.001); DME, -0.50 (91 eyes; 95% CI, -0.64 to -0.33; P < 0.001); and ME from NIU, -0.38 (198 eyes; 95% CI, -0.49 to -0.26; P < 0.001). Regarding change from baseline to 24 weeks for both BCVA and CST, Pearson correlation coefficients were: ME from RVO, -0.35 (95% CI, -0.43 to -0.27; P < 0.001); DME, -0.30 (95% CI, -0.48 to -0.09; P = 0.006); and ME from NIU, -0.42 (95% CI, -0.53 to -0.29; P < 0.001). Acute and chronic ME showed similar baseline and 24-week change linear correlations. With lower baseline CST, a trend of decreased baseline and 24-week change correlations was found. For central subfield EZ at baseline, mean BCVA progressively worsened with each of 4 EZ grades in 185 eyes with gradable EZ (DME, 41 eyes; NIU, 144 eyes; P ≤ 0.050 for all pairwise comparisons except between normal and questionably abnormal EZ grades). Eyes with normal baseline central subfield EZ showed greater 24-week change in BCVA than those with abnormal baseline EZ (15.00 letters vs. 8.16 letters; P = 0.0005, with baseline BCVA, CST, and age as covariates).

CONCLUSIONS

Despite these correlations, CST and EZ integrity, as graded herein, account for the minority of BCVA variation in patients with ME resulting from RVO, DR, and NIU.

摘要

目的

本研究评估了黄斑水肿(ME)患者最佳矫正视力(BCVA)、中心视网膜厚度(CST)和椭圆体带(EZ)完整性之间的关系。

设计

对 6 项临床试验进行了事后分析,这些试验包括经过验证的诊断、方案折射和阅读中心对 OCT 图像的评估。

参与者

参与者(n=1063)被诊断为视网膜静脉阻塞(RVO)、糖尿病视网膜病变(DR;糖尿病性黄斑水肿,DME)或非感染性葡萄膜炎(NIU)引起的 ME。

方法

对于 CST,对每种疾病的 2 项临床试验进行了分析。对于 EZ,对 2 种疾病的 3 项研究进行了分析。

主要观察指标

主要结局是 BCVA 与 CST 之间以及 BCVA 与 4 个中央视网膜厚度 EZ 等级之间的相关性。

结果

对于基线 BCVA 和 CST,Pearson 相关系数为:RVO 引起的 ME,-0.56(774 只眼;95%置信区间[CI],-0.61 至-0.51;P<0.001);DME,-0.50(91 只眼;95%CI,-0.64 至-0.33;P<0.001);NIU 引起的 ME,-0.38(198 只眼;95%CI,-0.49 至-0.26;P<0.001)。对于基线至 24 周时 BCVA 和 CST 的变化,Pearson 相关系数为:RVO 引起的 ME,-0.35(95%CI,-0.43 至-0.27;P<0.001);DME,-0.30(95%CI,-0.48 至-0.09;P=0.006);NIU 引起的 ME,-0.42(95%CI,-0.53 至-0.29;P<0.001)。急性和慢性 ME 表现出相似的基线和 24 周变化线性相关性。随着基线 CST 的降低,发现基线和 24 周变化相关性的趋势降低。对于基线中央视网膜厚度 EZ,在可分级 EZ(DME,41 只眼;NIU,144 只眼)的 185 只眼中,随着 4 个 EZ 等级的增加,平均 BCVA 逐渐恶化(P≤0.050,除正常和可疑异常 EZ 等级之间的比较外)。基线中央视网膜厚度 EZ 正常的眼比基线 EZ 异常的眼 24 周时 BCVA 的变化更大(15.00 个字母 vs. 8.16 个字母;P=0.0005,基线 BCVA、CST 和年龄作为协变量)。

结论

尽管存在这些相关性,但 CST 和 EZ 完整性,如本文所述,在 RVO、DR 和 NIU 引起的 ME 患者的 BCVA 变化中仅占少数。

相似文献

1
Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.视网膜静脉阻塞、糖尿病性和葡萄膜炎性黄斑水肿的视力:中心凹下视网膜厚度和椭圆体带分析。
Ophthalmol Retina. 2021 Jul;5(7):633-647. doi: 10.1016/j.oret.2020.10.016. Epub 2020 Oct 29.
2
Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.与视网膜静脉阻塞相关的黄斑水肿的解剖学生物标志物。
Ophthalmol Retina. 2022 Dec;6(12):1206-1220. doi: 10.1016/j.oret.2022.06.016. Epub 2022 Jun 30.
3
Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.抗血管内皮生长因子治疗继发于视网膜中央静脉阻塞的黄斑水肿的视力结果预测因素。
Ophthalmol Retina. 2021 Nov;5(11):1115-1124. doi: 10.1016/j.oret.2021.02.008. Epub 2021 Feb 19.
4
OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.玻璃体内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿患者短期视力的光学相干断层扫描预测指标
Retina. 2020 Apr;40(4):773-785. doi: 10.1097/IAE.0000000000002444.
5
Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.VISTA研究中糖尿病性黄斑水肿的光学相干断层扫描高阶评估:椭圆体带动态变化与视网膜液体指数
Ophthalmol Retina. 2019 Dec;3(12):1056-1066. doi: 10.1016/j.oret.2019.06.010. Epub 2019 Jul 6.
6
Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿后视力预后的频域光学相干断层扫描预测指标
Ophthalmol Retina. 2020 Jan;4(1):67-76. doi: 10.1016/j.oret.2019.08.009. Epub 2019 Aug 28.
7
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.雷珠单抗治疗糖尿病性黄斑水肿及黄斑无灌注的疗效:随机、对照、多中心 RIDE 和 RISE 研究
Ophthalmology. 2018 Oct;125(10):1568-1574. doi: 10.1016/j.ophtha.2018.04.002. Epub 2018 May 8.
8
Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.糖尿病性黄斑水肿治疗后深部毛细血管丛灌注与长期光感受器恢复之间的相关性
Ophthalmol Retina. 2018 Mar;2(3):235-243. doi: 10.1016/j.oret.2017.07.003. Epub 2017 Sep 28.
9
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema.光学相干断层扫描在葡萄膜炎性黄斑水肿中的解剖和时间生物标志物。
Am J Ophthalmol. 2022 May;237:310-324. doi: 10.1016/j.ajo.2021.10.024. Epub 2021 Nov 3.
10
Disorganization of Retinal Inner Layers and Ellipsoid Zone Disruption Predict Visual Outcomes in Central Retinal Vein Occlusion.视网膜内层结构紊乱和椭圆体带破坏可预测视网膜中央静脉阻塞的视觉预后。
Ophthalmol Retina. 2019 Jan;3(1):83-92. doi: 10.1016/j.oret.2018.07.008. Epub 2018 Oct 19.

引用本文的文献

1
Predicting Visual Acuity after Retinal Vein Occlusion Anti-VEGF Treatment: Development and Validation of an Interpretable Machine Learning Model.预测视网膜静脉阻塞抗VEGF治疗后的视力:一种可解释机器学习模型的开发与验证
J Med Syst. 2025 Apr 29;49(1):57. doi: 10.1007/s10916-025-02190-3.
2
Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual Outcomes.非结核病流行国家眼部结核患者的葡萄膜炎性黄斑水肿:特征、管理及视觉预后
Eye (Lond). 2025 Feb;39(3):593-601. doi: 10.1038/s41433-024-03577-1. Epub 2025 Jan 7.
3
Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies.
用于预测视网膜静脉阻塞相关性黄斑水肿治疗反应的光学相干断层扫描、多模态成像和细胞因子标志物的综合评估:抗血管内皮生长因子和类固醇疗法的比较性综述
Diagnostics (Basel). 2024 Sep 7;14(17):1983. doi: 10.3390/diagnostics14171983.
4
The central retinal thickness and its related genotype in ABCA4-related retinopathy.ABCA4 相关性视网膜病变的中心视网膜厚度及其相关基因型。
Eye (Lond). 2024 Oct;38(14):2718-2723. doi: 10.1038/s41433-024-03104-2. Epub 2024 May 13.
5
Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion.随机分组后 1 个月时视网膜厚度与中心静脉阻塞后厚度和视力的相关性。
Am J Ophthalmol. 2024 Oct;266:110-117. doi: 10.1016/j.ajo.2024.04.027. Epub 2024 May 3.
6
Case series of retinal vein occlusions showing early recovery using oral l-methylfolate.口服L-甲基叶酸显示早期恢复的视网膜静脉阻塞病例系列
Ther Adv Ophthalmol. 2024 Apr 15;16:25158414241240687. doi: 10.1177/25158414241240687. eCollection 2024 Jan-Dec.
7
Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.马来酸噻吗洛尔滴眼液,一种β阻断剂眼药水,可改善视网膜静脉阻塞模型中的水肿。
Mol Vis. 2023 Oct 15;29:188-196. eCollection 2023.
8
Clinical and imaging biomarkers of response to intravitreal dexamethasone implant in eyes with non-infectious uveitic macular oedema.玻璃体内注射地塞米松植入物治疗非感染性葡萄膜炎性黄斑水肿眼的临床和影像学应答生物标志物。
Eye (Lond). 2024 Apr;38(5):910-916. doi: 10.1038/s41433-023-02802-7. Epub 2023 Oct 30.
9
Corticosteroid implants for chronic non-infectious uveitis.皮质类固醇植入物治疗慢性非感染性葡萄膜炎。
Cochrane Database Syst Rev. 2023 Aug 29;8(8):CD010469. doi: 10.1002/14651858.CD010469.pub4.
10
Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema.探讨视网膜液作为糖尿病性黄斑水肿管理的生物标志物的作用。
Eye (Lond). 2024 Jan;38(1):54-60. doi: 10.1038/s41433-023-02637-2. Epub 2023 Jul 21.